Boston Tech
MassAITC Gets $24.5 Million to Give Aging-at-Home AI Some Adult Supervision
UMass Amherst and Mass General Brigham announce a nearly $24.5 million MassAITC renewal to test AI for aging at home, dementia care and caregiver support.
Boston Tech
UMass Amherst and Mass General Brigham announce a nearly $24.5 million MassAITC renewal to test AI for aging at home, dementia care and caregiver support.
Boston Tech
Boston’s ASI raised $325 million at a $3 billion valuation to expand infrastructure AI. Airline results show promise; nationwide deployment is the test.
Fintech
Money20/20 USA 2026’s weirdest first-full-day finds: IV drips, fraud-company escape rooms, robot portraits, golden licenses, merch coins, and Timbaland.
Boston Tech
Cambridge-based Tamr raised $21 million led by Volition Capital to expand AI data management, tackling duplicate records before enterprise agents use them.
Boston Tech
MIT-linked Ataraxos beats elite Stratego players with far less compute. A new Nature paper shows real progress, with real limits beyond the game board.
Boston Tech
Massachusetts announced nearly $40 million in life-sciences tax incentives tied to 1,644 jobs, backing Insulet, Lila Sciences and statewide expansion.
Boston Tech
Cambridge startup Subconscious announced $5.1 million for AI agent inference, betting context compression can cut costs without losing the plot.
Boston Tech
MIT’s HardFlow steers generative AI toward outputs that obey hard constraints, a promising research step for robotics with real-world limits still ahead.
Boston Tech
What could Anthropic work on in its Boston office? A snarky look at science, software, and AI safety—with plausible ideas clearly separated from confirmed plans.
Boston Tech
Anthropic’s Cambridge expansion gives Boston’s innovation economy a timely opening. The payoff depends on research, local startups, and more than office space.
AI
Meta launches Muse, a personal AI agent with a built-in Sentinel and bigger privacy promises coming later. Your digital butler arrives with supervision.
Boston Tech
Insilico’s rentosertib study links an AI-designed lung drug to lower aging-clock estimates, with Boston researchers and important limits on the findings.